Halozyme Therapeutics Inc logo

Halozyme Therapeutics Inc

FRA:RV7 (USA)   Ordinary Shares
€ 45.90 (+0.9%) Dec 27
15.94
P/B:
13.52
Market Cap:
€ 5.88B ($ 6.13B)
Enterprise V:
€ 6.68B ($ 6.97B)
Volume:
228.00
Avg Vol (2M):
566.00
Trade In:

Halozyme Therapeutics Inc Valuation Measures